BioWorld Asia

April 15, 2009

View Archived Issues

BioXell Shares Plunge on Elocalcitol Miss

BioXell SpA suffered a collapse in its share price following news that its vitamin D3 analogue elocalcitol failed to meet the primary endpoint of a Phase IIb trial in overactive bladder (OAB). (BioWorld International) Read More

ReNeuron Able to Automate Fetal Neural Stem Cell Process

Read More

China: Through New Initiatives it Seeks to Boost Innovation

Read More

Renovo Confirms it has a Suitor Waiting in the Wings

Read More

Amarin Eyes European OK for AMR101 in Huntington's

Read More

Study Supplies Missing Piece to Antibiotic Pump Puzzle

Read More

Canada and Europe to Work Together on Medicines

Read More

Biocortech Initiates Trial of Depression Blood Test

Read More

Other News To Note

Read More